Strategic Selection and Development of Immunogenicity Binding Methods 2012 is a webinar that covers topics such as:
- Technology platforms: Label dependent and label independent Feasibility and timeline
- Regulatory expectations
- Controls and reagents: Preparation, storage and stability
- Assay formats: Bridging and direct
- Optimization: MFAT/DOE versus OFAT
- Feasibility Storage of cell banks to certify stability
- Check-list for validation
- Pre-validation
Strategic Selection and Development of Immunogenicity Binding Methods 2012 brings together:
- Bioanalytical specialists
- Immunogenicity analysts
- Project Managers
- QA/QC
- ConsultantsImmunogenicity analysts
- Regulatory personnel
- QA/QC
- Bioanalytical specialists
- Regulatory personnel
- Project Managers
- Consultants
